|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the University of Washington, Seattle, WA.
Correspondence to: Mark R. Tonelli, MD, MA, FCCP, Box 356522, 1959 NE Pacific St, Seattle, WA 98195-6522; e-mail: tonelli{at}u.washington.edu
Abstract
Conflicts of interest, ubiquitous in medicine, occur when the interests of clinicians do not align with the interests of their patients. When systemic and institutionalized, such conflicts become particularly problematic, not only creating risks for individual patients but also undermining the integrity of the medical profession. Financial conflicts of interest arise when the reimbursement of clinicians appears to encourage decisions and actions that are unlikely to be in the best interest of individual patients. More insidiously, the influence of the pharmaceutical and medical device industry on clinicians, whether through gift giving, support of continuing medical education, or guideline development, creates conflicts of interest that may go unrecognized. Recognition and acknowledgment are the first steps in ameliorating conflicts of interest, which can then be disclosed and potentially eliminated.
Key Words: conflict of interest disclosure ethics
Related Articles
Related Editorial
Chest 2008 133: 775-786.
Chest 2007 131: 1532-1540.
Chest 2007 131: 563-568.
Chest 2006 130: 1864-1872.
Chest 2007 132: 370-372.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |